|
Regulation of Tumor Cell Migration by Mitochondrial Superoxide Dismutase
|
5F32CA134165-03
|
$57,686
|
$57,686
|
Hempel, Nadine
|
ALBANY MEDICAL COLLEGE
|
|
Dissecting sarcoma complexity via innovative microRNA and informatics approaches
|
1K22CA138716-01A2
|
$191,160
|
$95,580
|
Spentzos, Dimitrios
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
2R01CA082036-11A2
|
$397,221
|
$397,221
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Polymer chelate conjugates for diagnostic cancer imaging
|
5R01CA097465-07
|
$251,200
|
$82,896
|
LU, ZHENG-RONG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Oncolytic HSV Therapy in Immunocompetent Sarcoma Models
|
5R01CA114004-05
|
$258,529
|
$258,529
|
CRIPE, TIMOTHY
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Hsp90 as a Target for the Treatment of Childhood Cancer
|
5K23CA107450-06
|
$119,402
|
$119,402
|
BAGATELL, ROCHELLE
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Genetics of pediatric rhabdoid tumors
|
5R01CA046274-19
|
$266,860
|
$88,064
|
BIEGEL, JACLYN
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Cancer Center Support Grant
|
3P30CA033572-27S1
|
$94,753
|
$948
|
friedman, michael
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-27S2
|
$100,000
|
$1,000
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-27S3
|
$101,205
|
$1,012
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-27S4
|
$151,808
|
$1,518
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA033572-27
|
$2,318,695
|
$23,187
|
friedman, michael
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Inhibitors in Src Signaling for Antitumor Therapy
|
5R01CA115674-04
|
$288,990
|
$144,495
|
Jove, Richard
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
TRAIL Therapy for Rhabdomyosacrcoma
|
5R01CA087952-09
|
$234,840
|
$234,840
|
HOUGHTON, JANET
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Total Synthesis and Biosynthesis of Bioactive Substances
|
5R01CA070375-14
|
$246,768
|
$12,338
|
WILLIAMS, ROBERT
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
|
Cancer Center Support Grant
|
3P30CA013696-37S1
|
$100,000
|
$1,000
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-37
|
$4,017,288
|
$40,173
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The role of DKK1, a Wnt-Inhibitor, in Mesenchymal Differentiation/Sarcomagenesis
|
5K08CA132986-02
|
$169,884
|
$169,884
|
MATUSHANSKY, IGOR
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Columbia-South Africa Training Program for Research on HIV-associated Malignanci
|
1D43CA153715-01
|
$493,657
|
$167,843
|
NEUGUT, ALFRED
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Epidemiology of Syndromic GI Stromal Tumors
|
5R01CA125176-04
|
$449,094
|
$449,094
|
GARBER, JUDY
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA023108-32S1
|
$100,000
|
$1,000
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-32S2
|
$87,459
|
$875
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-32S3
|
$100,000
|
$1,000
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
5P30CA023108-32
|
$3,290,263
|
$32,903
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Immune surveillance in murine gammaherpesvirus infection
|
5R01CA103642-07
|
$418,918
|
$142,432
|
Usherwood, Edward
|
DARTMOUTH COLLEGE
|
|
Viral Oncology Training Grant
|
5T32CA009111-33
|
$296,458
|
$29,646
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Dissecting Mechanisms of Metastasis Through Comparative Systems Genetics
|
5R01CA138265-03
|
$476,541
|
$476,541
|
KIRSCH, DAVID
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
2P30CA014236-36
|
$6,070,886
|
$60,709
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-36S1
|
$100,000
|
$1,000
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-36S2
|
$36,382
|
$364
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-36S3
|
$99,857
|
$998
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Role of MAPK signaling in Kaposi's sarcoma-associated herpersvirus pathogenesis
|
5F31CA132560-03
|
$28,768
|
$28,768
|
Dyson, Ossie
|
EAST CAROLINA UNIVERSITY
|
|
The Molecular Actions of Imatinib Mesylate in GISTs
|
5R01CA106588-07
|
$433,446
|
$433,446
|
GODWIN, ANDREW
|
FOX CHASE CANCER CENTER
|
|
The ARF Tumor Suppressor
|
1R01CA139319-01A1
|
$362,088
|
$90,522
|
MURPHY, MAUREEN
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-47S6
|
$100,000
|
$4,000
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-47S7
|
$8,241,288
|
$329,652
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-47S8
|
$105,935
|
$4,237
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-47S9
|
$350,000
|
$14,000
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Impact of HIV and HHV-8 Co-Infection on Antiretroviral Therapy Efficacy in Africa
|
1R01CA138165-01A2
|
$346,681
|
$173,341
|
CASPER, COREY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Association between HIV and Survival after Cancer Diagnosis
|
1R03CA153371-01
|
$88,000
|
$22,000
|
NEWCOMB, POLLY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The East Coast AIDS and Cancer Specimen Resource
|
5U01CA066535-16
|
$1,031,638
|
$257,910
|
SILVER, SYLVIA
|
GEORGE WASHINGTON UNIVERSITY
|
|
Regulation of Cellular Proteins by KSHV RAP and RTA
|
5R01CA073585-14
|
$397,126
|
$397,126
|
HAYWARD, GARY
|
JOHNS HOPKINS UNIVERSITY
|
|
Studies of HHV-8 vIL-6 Function
|
2R01CA076445-10A2
|
$360,375
|
$180,188
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
Mechanism of regulation for the oncogenic Pax3-FOXO1 in Alveolar Rhabdomyosarcoma
|
5R01CA138656-02
|
$294,650
|
$294,650
|
HOLLENBACH, Andrew
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
Impact of Vaccination against GM2, GD2 and GD3 on Disease Free Survival in Resect
|
1R44CA153561-01
|
$150,000
|
$150,000
|
Scholz, Wolfgang
|
MABVAX THERAPEUTICS, INC.
|
|
Regulation and Function of Mammalian HSF4 in vivo
|
5R01CA132640-10
|
$265,594
|
$132,797
|
MIVECHI, NAHID
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
|
Anti-tumorigenic Activity of Adenovirus E1A
|
5R01CA125666-04
|
$287,850
|
$287,850
|
Routes, John
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-02S1
|
$88,205
|
$3,528
|
KRAFT, ANDREW
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-02S2
|
$84,727
|
$3,389
|
KRAFT, ANDREW
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-02S3
|
$48,882
|
$1,955
|
KRAFT, ANDREW
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
Total relevant funding to Sarcoma, Soft (Sarcoma Subset) for this search: $44,230,921
|